Home
Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Sell · Filed 24/10/10
Trade details
- Type
- Insider sale
- Amount
- $389,611.6
- Shares · price
- 13,880 sh · $28.07 a share
- Held after
- 1,006,646 sh
- Trade date
- 24/10/09
- Filed
- 24/10/10
- Days to filing
- 1 days
Sold 1.4% of holdings
- Share of holding sold
- 1.4%
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 24/09/09~24/11/08Samuel Kintz's recent trades
- Samuel Kintz
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 planEnliven Therapeutics
ELVN
$2M
75,000 sh
$2M
Filed 02/17
Traded 02/17
- Samuel Kintz
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 planEnliven Therapeutics
ELVN
$1.7M
75,000 sh
$1.7M
Filed 01/09
Traded 01/09
- Samuel Kintz
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 planEnliven Therapeutics
ELVN
$1.3M
82,500 sh
$1.3M
Filed 01/08
Traded 01/08
- Samuel Kintz
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 planEnliven Therapeutics
ELVN
$84.6K
5,000 sh
$84.6K
Filed 25/12/17
Traded 25/12/17
- Samuel Kintz
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 planEnliven Therapeutics
ELVN
$272.8K
12,500 sh
$272.8K
Filed 25/11/19
Traded 25/11/17